Anke Krebber

USPTO Granted Patents = 21 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 108(Granted Patents)

Location History:

Mountain View, CA (US) (2003 - 2010)
Palo Alto, CA (US) (2008 - 2022)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12415990 - Ketoreductase polypeptides for the reduction of acetophenones (2025-09-16),

2. 11479756 - Ketoreductase polypeptides for the reduction of acetophenones (2022-10-25),

3. 10927351 - Ketoreductase polypeptides for the reduction of acetophenones (2021-02-23),

4. 10227572 - Ketoreductase polypeptides for the reduction of acetophenones (2019-03-12),

5. 10100288 - Ketoreductase polypeptides for the reduction of acetophenones (2018-10-16),

6. 9951318 - Ketoreductase polypeptides for the reduction of acetophenones (2018-04-24),

7. 9873863 - Polynucleotides encoding ketoreductase polypeptides for reduction of acetophenones (2018-01-23),

8. 9528131 - Methods of using ketoreductase polypeptides for reduction of acetophenones (2016-12-27),

9. 9228223 - Structure-activity relationships (2016-01-05),

10. 8852909 - Ketoreductase polypeptides for the reduction of acetophenones (2014-10-07),

11. 8748143 - Ketoreductase polypeptides for the reduction of acetophenones (2014-06-10),

12. 8614081 - Nitrilase biocatalysts (2013-12-24),

13. 8569013 - Penicillin-G acylases (2013-10-29),

14. 8512973 - Methods of using engineered ketoreductase polypeptides for the stereoselective reduction of acetophenones (2013-08-20),

15. 8247192 - Penicillin-G acylases (2012-08-21),

Title: Anke Krebber: Pioneering Advances in Ketoreductase Enzymes

Introduction

Anke Krebber, based in Palo Alto, California, is an accomplished inventor with a remarkable portfolio of 20 patents to her name. Her work primarily focuses on engineered enzymes, particularly ketoreductases, which have significant implications in synthetic chemistry and biocatalysis.

Latest Patents

Among her latest contributions are innovative patents related to ketoreductase polypeptides that enhance the reduction of acetophenones. These patents detail engineered ketoreductase enzymes with improved attributes compared to their naturally occurring wild-type counterparts. Furthermore, they include polynucleotides that encode these engineered enzymes, alongside host cells capable of expressing them. The methods described facilitate the synthesis of various chiral compounds, showcasing the versatility and impact of her inventions in the field.

Career Highlights

Anke has held pivotal roles in esteemed companies such as Codexis, Inc. and Pfizer Corporation. Her experiences at these leading organizations have propelled her to the forefront of enzyme technology and innovation. Throughout her career, she has consistently pushed the boundaries of research and development in biocatalysis.

Collaborations

Anke has collaborated with talented colleagues like Emily Mundorff and Stephane J Jenne. Their combined efforts and expertise have contributed to the success of several projects and enhancements in enzyme engineering, underscoring the collaborative nature of scientific advancements.

Conclusion

Anke Krebber stands out as a significant figure in the field of enzyme technology. Her innovative patents and collaborations demonstrate her commitment to advancing biocatalysis and synthetic chemistry. With her background and expertise, she is likely to continue making impactful contributions in the realm of enzymatic research and development.

This text is generated by artificial intelligence and may not be accurate.